当前位置:主页 > 医学论文 > 神经病学论文 >

大鼠miR-185-3p调控的TrkB.FL信号通路抑制神经元痫样放电的研究

发布时间:2018-08-11 09:21
【摘要】:研究目的: 癫痫(Epilepsy)是一种常见的神经系统疾病,在研究癫痫发病机制的基础上,探索抑制癫痫发作的有效途径,具有重要的科学意义和临床应用价值。本论文在癫痫发生的TrkB (tropomyosin-related kinase B)受体和TrkB信号通路角度,以大鼠海马神经元痫样放电模型(spontaneous recurrent epileptiform discharges, SREDs)为研究对象,通过大鼠miR-185-3p(miR-185*)激活全长型TrkB(TrkB.FL)信号通路,研究神经元电压门控性Ca2+通道(Voltage-gated calcium channels, VGCCs)特性和痫样放电的抑制情况。探讨TrkB.FL信号通路激活后抑制癫痫发生的机制,为临床治疗癫痫提供创新的调控思路。 研究方法: 1.通过无镁液处理原代培养的大鼠海马神经元3h,构建神经元痫样放电模型。 2.研究TrkB受体和TrkB信号通路在痫样放电模型中的变化机制。 (1)通过实时荧光定量PCR和western blotting检测全长型TrkB(TrkB.FL)和截短型TrkB(TrkB.T)受体在模型中的表达水平,并应用钙蛋白酶抑制剂和转录翻译抑制剂研究调控TrkB受体表达变化的机制。 (2)使用BDNF处理模型,应用western blotting检测磷酸化TrkB.FL受体蛋白的表达水平,研究模型中TrkB受体表达变化调控TrkB.FL信号通路活性的相关机制。 3.研究miR-185*调控TrkB.FL信号通路活性后对痫样放电的影响。 (1)利用包含miR-185*-pGLVHl/GFP表达载体的慢病毒转染模型,实时荧光定量PCR和western blotting检测TrkB.T受体表达和TrkB.FL信号通路活性的改变。 (2)全细胞膜片钳检测miR-185*转染模型中神经元VGCC电流和稳态激活与失活特性的变化。 (3)全细胞膜片钳检测miR-185*转染模型中神经元放电的频率变化情况。 4.应用翻译抑制剂孵育痫样放电模型,通过全细胞膜片钳检测神经元放电频率的变化,研究TrkB.FL信号通路活性改变后对痫样放电的影响。 研究结果: 1.大鼠海马神经元痫样放电模型的鉴定结果: 与正常对照组神经元相比,模型组中神经元放电频率显著上升(P0.001, n=9), inter-event interval累计分布曲线明显左移(P0.001,n=9)。 2.TrkB受体和TrkB信号通路在痫样放电模型中的变化结果: (1)在痫样放电模型中,TrkB.T受体较正常对照组表达增加(P0.001,n=6),TrkB.FL受体表达降低(P0.001,n=6)。与模型组相比,钙蛋白酶抑制剂孵育模型后,TrkB.FL受体表达上升(P0.001,n=6);转录或翻译抑制剂孵育模型后,TrkB.T受体表达均下降(P0.001,n=6)。 (2)与正常对照孵育BDNF组相比,BDNF处理痫样放电模型,或者BDNF处理模型再孵育钙蛋白酶抑制剂,以上两组磷酸化的TrkB.FL受体蛋白与总TrkB.FL受体蛋白的比值(pTrkB.FL/total TrkB.FL)均降低(P0.01,n=6),证明TrkB.FL信号通路活性被抑制。而BDNF处理痫样放电模型再孵育翻译抑制剂后,与BDNF处理模型组相比,pTrkB.FL/total TrkB.FL比值升高(P0.001, n=6), TrkB.FL信号通路被激活。 3.利用miR-185*调控TrkB.FL信号通路活性后影响痫样放电的研究结果: (1)利用miR-185*转染痫样放电模型72h后,miR-185*在模型中持续大量的表达,并调控模型中TrkB.T受体表达减少(P0.001, n=6)。miR-185*转染痫样放电模型后再经BDNF处理,与BDNF处理模型组相比,pTrkB.FL/total TrkB.FL比值上升(P0.001,n=4),TrkB.FL信号通路同样被激活。 (2)痫样放电模型组中神经元VGCC电流和稳态激活与失活特性的相关参数与正常对照组比较后发现,VGCC最大电流密度升高(P0.001,n=10-15);激活曲线的V1/2和斜率因子k显著降低(P0.001,n=7-10)。表示VGCC激活的阈电位减小,激活速度加快,通道相对容易被激活。模型组VGCC失活曲线的V1/2显著增加(P0.001,n=7-9),而斜率因子k却显著降低(P0.001,n=7-9)。表示VGCC失活的阈电位增加,失活速度变慢,通道相对更难失活。 而miR-185*转染痫样放电模型后,VGCC特性的相关参数与未经转染的模型组相比,VGCC最大电流密度降低(P0.001,n=10.15);激活曲线的V1/2显著增加(P0.01,n=7-10),斜率因子k也显著升高(P0.001,n=7-10)。表示VGCC激活的阈电位升高,激活速度降低,通道相对难以激活。而VGCC失活曲线的V1/2变化虽然降低,但不显著(P0.05,n=7-9),反而斜率因子k显著升高(P0.05,n=7-9),表明VGCC失活速度加快,通道相对更容易失活。 (3)miR-185*转染痫样放电模型后,与未经处理的模型相比,神经元放电频率显著降低(P0.001,n=9),其inter-event interval累计分布曲线右移(P0.001,n=9),结果显示转染模型神经元的痫样放电减弱。 4.应用翻译抑制剂孵育痫样放电模型,TrkB.FL信号通路变化后对痫样放电的调节结果: 与未经处理的模型相比,翻译抑制剂孵育模型后的神经元放电频率显著降低(P0.001,n=9), inter-event interval累计分布曲线右移(P0.001,n=9),神经元的痫样放电同样减弱。 结论: 1.大鼠海马神经元经无镁液处理3h后,成功构建痫样放电模型。 2.痫样放电模型中,钙蛋白酶调控TrkB.FL受体表达减少,转录翻译过程参与 TrkB.T受体表达的增加。TrkB.T受体的高表达抑制模型中TrkB.FL信号通路的激活。 3.miR-185*激活TrkB.FL信号通路后,抑制痫样放电的产生。 (1)miR-185*转染痫样放电模型,通过下调TrkB.T受体的表达,可以激活TrkB.FL信号通路。 (2)激活的TrkB.FL信号通路抑制miR-185*转染模型神经元的VGCC电流和通道活性。 (3)激活的TrkB.FL信号通路降低miR-185*转染模型神经元的放电频率。 4.翻译抑制剂孵育痫样放电模型,激活的TrkB.FL信号通路同样降低了神经元的放电频率,最终抑制痫样放电。
[Abstract]:Research purposes:
Epilepsy is a common nervous system disease. Based on the study of the pathogenesis of epilepsy, it is of great scientific significance and clinical value to explore effective ways to inhibit epileptic seizures. The spontaneous recurrent epileptiform discharges (SREDs) were used to study the characteristics of voltage-gated Ca2+ channels (VGCCs) and the inhibition of epileptiform discharges in neurons by activating the full-length TrkB (TrkB.FL) signaling pathway with rat microRNA185-3p (microRNA185*). The mechanism of inhibiting epilepsy after pathway activation provides innovative regulatory ideas for clinical treatment of epilepsy.
Research methods:
1. The epileptiform discharge model of primary cultured rat hippocampal neurons was established by treating them with magnesium-free solution for 3 hours.
2. to study the mechanism of TrkB receptor and TrkB signaling pathway in epileptiform discharges.
(1) The expression levels of full-length TrkB (TrkB.FL) and truncated TrkB (TrkB.T) receptors were detected by real-time fluorescence quantitative PCR and Western blotting. Calpain inhibitors and transcriptional translation inhibitors were used to study the mechanism of regulating the expression of TrkB receptors.
(2) Western blotting was used to detect the expression of phosphorylated TrkB.FL receptor protein in BDNF treatment model, and the mechanism of TrkB.FL signaling pathway activity was studied.
3. to study the effect of miR-185* on the epileptiform discharges after regulating the activity of TrkB.FL signaling pathway.
(1) The expression of TrkB.T receptor and the activity of TrkB.FL signaling pathway were detected by real-time fluorescence quantitative PCR and Western blotting using a lentiviral transfection model containing the expression vector of Mi-185*-pGLVHl/GFP.
(2) Whole-cell patch clamp technique was used to detect the changes of VGCC current and steady-state activation and inactivation of neurons in the model of microarray-185 * transfection.
(3) whole cell patch clamp test was used to detect the frequency of neuronal firing in miR-185* transfection model.
4. Using the model of epileptiform discharges incubated by translation inhibitors, the changes of neuronal discharge frequencies were detected by whole-cell patch clamp to study the effects of changes in TrkB.FL signaling pathway activity on epileptiform discharges.
Research findings:
1. the epileptic discharge model of rat hippocampal neurons was identified.
Compared with the normal control group, the discharge frequency of neurons in the model group increased significantly (P 0.001, n = 9), and the cumulative distribution curve of inter-event interval shifted significantly to the left (P 0.001, n = 9).
The changes of 2.TrkB receptor and TrkB signaling pathway in epileptiform discharges model:
(1) In the epileptiform discharge model, the expression of TrkB.T receptor increased (P 0.001, n = 6) and the expression of TrkB.FL receptor decreased (P 0.001, n = 6) compared with the normal control group.
(2) The ratio of phosphorylated TrkB.FL receptor protein to total TrkB.FL receptor protein (pTrkB.FL/total TrkB.FL) in BDNF-treated epileptiform discharges model or BDNF-treated model was lower than that in BDNF-treated group (P 0.01, n=6), suggesting that the activity of TrkB.FL signaling pathway was inhibited. The ratio of pTrkB.FL/total TrkB.FL increased (P 0.001, n=6) and the TrkB.FL signaling pathway was activated in the BDNF treated group after incubation of the TrkB.FL inhibitor.
3. using miR-185* to regulate the activity of TrkB.FL signaling pathway, the results of epileptiform discharges were studied.
(1) After 72 hours of transfection of epileptiform discharge model with microRNAs-185 * the expression of microRNAs-185 * in the model continued to increase, and the expression of TrkB.T receptor decreased (P 0.001, n = 6). After transfection of epileptiform discharge model with microRNAs-185 * and BDNF treatment, the ratio of pTrkB.FL/total TrkB.FL increased (P 0.001, n = 4), and the TrkB.FL signaling pathway was the same as that of BDNF treatment group. Activated.
(2) Compared with the normal control group, the parameters related to VGCC current and steady-state activation and inactivation of neurons in the epileptiform discharge model group showed that the maximum current density of VGCC increased (P 0.001, n = 10-15), and the V1/2 and slope factor K of activation curve decreased significantly (P 0.001, n = 7-10). V1/2 of the VGCC inactivation curve increased significantly (P 0.001, n=7-9) while the slope factor K decreased significantly (P 0.001, n=7-9). This indicated that the threshold potential of VGCC inactivation increased, the inactivation rate slowed down, and the channel was relatively more difficult to inactivate.
Compared with the untransfected group, the maximum current density of VGCC decreased (P 0.001, n = 10.15), the V1/2 of the activation curve increased significantly (P 0.01, n = 7-10), and the slope factor K increased significantly (P 0.001, n = 7-10). V1/2 of VGCC inactivation curve decreased, but not significantly (P 0.05, n = 7-9), but the slope factor K increased significantly (P 0.05, n = 7-9), indicating that VGCC inactivation speed increased, and the channel was relatively easier to inactivate.
(3) Compared with untreated model, the discharge frequency of neurons was significantly decreased (P 0.001, n = 9) and the cumulative distribution curve of inter-event interval shifted to the right (P 0.001, n = 9) after transfection of microRNA185* into the epileptiform discharge model. The results showed that the epileptiform discharge of neurons in the transfected model was decreased.
4. Using the model of epileptiform discharges incubated by translation inhibitors, the regulation of TrkB.FL signaling pathway on epileptiform discharges was studied.
Compared with the untreated model, the firing frequency of the neurons incubated with the translation inhibitor decreased significantly (P 0.001, n=9), the cumulative distribution curve of inter-event interval shifted to the right (P 0.001, n=9), and the epileptiform discharge of the neurons also decreased.
Conclusion:
1. rat hippocampal neurons were treated with magnesium free solution for 3h, and epileptiform discharges were successfully constructed.
2. In the epileptiform discharge model, the expression of TrkB.FL receptor is decreased and transcriptional translation is involved.
Increased expression of TrkB.T receptor. Activation of TrkB.FL signaling pathway in the TrkB.T receptor overexpression inhibition model.
3.miR-185* activates the TrkB.FL signaling pathway and suppresses epileptiform discharges.
(1) Mi-185* transfected epileptiform discharge model can activate TrkB.FL signaling pathway by down-regulating the expression of TrkB.T receptor.
(2) Activated TrkB.FL signaling pathway inhibits the VGCC current and channel activity in the model neurons transfected with miR-185*
(3) activation of TrkB.FL signaling pathway reduces the firing frequency of neurons in miR-185* transfection model.
4. Translator inhibitors incubate epileptiform discharges. Activated TrkB.FL signaling pathway also reduces the frequency of neuronal discharges and ultimately inhibits epileptiform discharges.
【学位授予单位】:天津医科大学
【学位级别】:博士
【学位授予年份】:2014
【分类号】:R742.1

【共引文献】

相关期刊论文 前10条

1 吴春蓉;罗治彬;;肿瘤相关性microRNA在胃癌研究中的新进展[J];国际消化病杂志;2010年01期

2 彭雅亚;;AKT-1在乳腺良恶性病变中的表达及其临床意义[J];标记免疫分析与临床;2013年04期

3 隗黎丽;吴华东;熊六凤;;柱状黄杆菌对草鱼TLRs基因表达水平的影响[J];大连海洋大学学报;2013年04期

4 谢婧雯;刘晓燕;;Akt信号转导通路在心血管系统中作用的研究进展[J];重庆医学;2013年30期

5 廖萌;严孙杰;;成骨细胞Toll样受体4信号通路研究进展[J];中华骨质疏松和骨矿盐疾病杂志;2013年03期

6 李致宏;马振刚;李晚军;刘军;韩冰;李田;潘国庆;李春峰;周泽扬;;感染家蚕微孢子虫的蚕体血淋巴蛋白质差异表达分析及质谱鉴定[J];蚕业科学;2013年05期

7 余梦辰;李斌;周红;;内毒素识别、内化及清除相关受体的研究进展[J];重庆医学;2013年29期

8 肖玲;舒畅;唐记华;王晓萍;王高华;;不同时程的慢性不可预计温和应激对大鼠海马神经可塑性相关蛋白水平的影响[J];神经损伤与功能重建;2013年06期

9 冯娅妮;孙艳红;马虹;;丙泊酚预处理对SK-N-SH神经母细胞缺氧/复氧损伤的保护作用[J];广东医学;2013年22期

10 王德勇;徐慧高;;Akt/mTOR信号通路与口腔鳞状细胞癌的研究进展[J];蚌埠医学院学报;2013年11期

相关会议论文 前1条

1 Wei Long;Jinhang Zan;Zewei Zhou;Xin He;Jin Jin;Saijun Fan;Peixun Liu;;Computational Simulation for Binding Interaction of TLR5 with Flagellin[A];第二届国际计算科学与工程国际学术研讨会论文集[C];2013年

相关博士学位论文 前10条

1 周嘉梁;MicroRNA-142-3p对结直肠癌生物学行为的影响及作用机制的初步研究[D];苏州大学;2013年

2 李莲莲;感觉神经节对脑运动神经元轴突生长的影响及其分子机制[D];兰州大学;2013年

3 宗灿华;奶牛乳腺主要乳成分合成代谢的转录组学研究[D];东北农业大学;2013年

4 赵一萍;蒙古马免疫相关基因表达研究及脾脏表达谱分析[D];内蒙古农业大学;2013年

5 薛雪;AQP4基因缺失对中脑TGF-β产生的影响及其与帕金森疾病的相关研究[D];南京医科大学;2013年

6 王晶晶;中华绒螯蟹免疫致敏现象及相关分子机制的初步研究[D];中国科学院研究生院(海洋研究所);2013年

7 王雷雷;扇贝补体相关分子的结构及功能研究[D];中国科学院研究生院(海洋研究所);2013年

8 袁世英;AMPK信号通路在大鼠慢性糖皮质激素应激中的作用及机制[D];华中科技大学;2013年

9 赵敏;高脂饮食对大鼠肝脏内质网应激和炎症的影响及低脂膳食干预效果研究[D];华中科技大学;2013年

10 李莉;脑红蛋白对神经元突起生长的作用及其潜在机制[D];华中科技大学;2013年

相关硕士学位论文 前10条

1 朱恩东;幽门螺杆菌感染相关miR-30b在胃癌发生中的功能研究[D];第三军医大学;2011年

2 叶敏;miRNAs在胃癌中的差异表达[D];广州医学院;2010年

3 唐仪;二烯丙基二硫抑制人胃低分化腺癌增殖的转录组学研究[D];南华大学;2010年

4 赵达;鼠伤寒沙门氏菌鞭毛蛋白对牛金黄色葡萄球菌GapC蛋白的免疫增强作用[D];黑龙江八一农垦大学;2013年

5 杨丽敏;脑源性神经营养因子Val66Met基因多态性与中国汉族精神分裂症认知功能的相关性研究[D];山东大学;2013年

6 张惠莉;骨髓间充质干细胞移植改善慢性脑缺血大鼠空间学习记忆能力并影响BDNF及P75NTR表达[D];郑州大学;2013年

7 杨颖珂;骨髓间充质干细胞移植对脑出血大鼠血肿周围凋亡及P75NTR、TrkA表达的影响[D];郑州大学;2013年

8 刘晓东;GDC-0941诱导人食管癌EC9706细胞凋亡及相关机制的研究[D];郑州大学;2013年

9 徐汉阳;拟南芥EFR与黑腹果蝇SCOT蛋白重组表达、纯化及晶体研究[D];安徽大学;2013年

10 王志明;FBXW7和Ki-67在人脑胶质瘤中的表达及临床意义[D];河北医科大学;2013年



本文编号:2176573

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/shenjingyixue/2176573.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户5eb10***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com